BD BACTEC Blood Culture System Recall 1,086 Units Worldwide Over Unauthorized Access Risk (2025)
BD recalled 1,086 BD BACTEC Blood Culture System units worldwide after unauthorized access to product service credentials. The breach could compromise confidentiality, integrity and availability of affected devices and data. Hospitals and healthcare providers should stop using the device immediately and follow BD’s recall instructions.
Quick Facts at a Glance
Recall Date
September 23, 2025
Hazard Level
HIGH
Brand
BD
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL
Hazard Information
Product service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated data.
What You Should Do
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Becton Dickinson & Co. or your healthcare provider for instructions. Notification method: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
No spamUnsubscribe anytime
About This Product
The BD BACTEC Blood Culture System is used in clinical laboratories to detect bloodstream infections by incubating blood culture bottles and signaling growth. It is deployed across hospitals and healthcare facilities to guide sepsis diagnosis.
Why This Is Dangerous
The recall is prompted by unauthorized access to product service credentials. If exploited, this could allow access to device software or data, potentially compromising patient data and system availability.
Industry Context
This recall is not described as part of a broader industry pattern in the provided notice.
Real-World Impact
Hospitals may experience downtime or need to implement additional cybersecurity controls while awaiting remediation. There is potential for data exposure related to device service credentials.
Practical Guidance
How to identify if yours is affected
Check device label for catalog numbers 445570, 445702, 44557008
Review serial numbers listed (e.g., 445570) and the UDI/DI: 00382904455705
Cross-check with the recall notice and FDA enforcement page to verify status
Where to find product info
FDA enforcement page and BD’s official recall notices
What timeline to expect
Remediation and replacement processes typically take weeks to months, depending on BD’s remediation plan and facility needs
If the manufacturer is unresponsive
Document all communications with BD
Escalate to your hospital’s risk management or biosafety officer
If needed, contact the FDA for guidance on unresponsive manufacturers
How to prevent similar issues
Limit access to device service credentials; enforce strong authentication and access controls
Keep device firmware and software up to date per vendor guidance
Verify vendor communications through official channels before acting
Maintain an inventory of affected devices and monitor for updates
Documentation advice
Save all recall notices, emails, and vendor communications; photograph labels and serials; log dates and actions taken
BD recalled 177 units of the BACTEC Blood Culture System worldwide after an unauthorized actor accessed product service credentials. The breach could allow unauthorized access to system configurations and data. Healthcare facilities should stop using the affected equipment and follow BD’s recall instructions.
BD recalled 38 Veritor Connect Software units distributed to healthcare providers worldwide. Unauthorized access to product service credentials could affect confidentiality, integrity or availability of the product and data. Stop using the software and follow the recall instructions provided by the manufacturer.
BD MAX System recall affects 62 units distributed worldwide in 2025 after unauthorized access to service credentials. An unauthorized actor accessed credentials used by BD technical support teams. Healthcare providers should stop using the devices and follow the manufacturer’s recall instructions.
BD recalled 4,283 Phoenix M50 Automated Microbiology Systems worldwide after unauthorized access to product service credentials. The unauthorized actor could access affected products and data. Labs should stop using these devices and follow the recall instructions from BD; contact BD for remediation guidance.
CareFusion 303 BD Alaris infusion pump modules and compatible infusion sets are recalled nationwide in the U.S. and multiple international markets. The recall covers reference numbers including C24101E and 10015414 and related SmartSite components. The defect may cause flow rate and bolus accuracy deviations, and incorrect occlusion timing. Stop using the device and follow recall instructions from